Kaisa Health Group Holdings Croissance future

Future contrôle des critères 0/6

Nous ne disposons actuellement pas d'une couverture d'analyste suffisante pour prévoir la croissance et les revenus de Kaisa Health Group Holdings.

Informations clés

n/a

Taux de croissance des bénéfices

n/a

Taux de croissance du BPA

Medical Equipment croissance des bénéfices	40.1%
Taux de croissance des recettes	n/a
Rendement futur des capitaux propres	n/a
Couverture par les analystes	None
Dernière mise à jour	n/a

Mises à jour récentes de la croissance future

Recent updates

Investors Aren't Buying Kaisa Health Group Holdings Limited's (HKG:876) Revenues

Sep 25

Here's Why Shareholders Should Examine Kaisa Health Group Holdings Limited's (HKG:876) CEO Compensation Package More Closely

Jun 07

Benign Growth For Kaisa Health Group Holdings Limited (HKG:876) Underpins Stock's 30% Plummet

Feb 07

Kaisa Health Group Holdings Limited's (HKG:876) Prospects Need A Boost To Lift Shares

Dec 21

The Market Doesn't Like What It Sees From Kaisa Health Group Holdings Limited's (HKG:876) Earnings Yet As Shares Tumble 42%

Jun 07

We're A Little Worried About Kaisa Health Group Holdings' (HKG:876) Cash Burn Rate

Mar 14

Here's Why Kaisa Health Group Holdings (HKG:876) Must Use Its Cash Wisely

Oct 12

Kaisa Health Group Holdings' (HKG:876) Profits Appear To Have Quality Issues

Oct 05

We Think Kaisa Health Group Holdings (HKG:876) Can Afford To Drive Business Growth

Jul 30

Would Shareholders Who Purchased Kaisa Health Group Holdings' (HKG:876) Stock Five Years Be Happy With The Share price Today?

Jan 26

Dans cette section, nous présentons généralement des projections de croissance du chiffre d'affaires et des bénéfices basées sur les estimations consensuelles d'analystes professionnels afin d'aider les investisseurs à comprendre la capacité de l'entreprise à générer des bénéfices. Mais comme Kaisa Health Group Holdings n'a pas fourni suffisamment de données passées et n'a pas de prévisions d'analystes, ses bénéfices futurs ne peuvent pas être calculés de manière fiable en extrapolant les données passées ou en utilisant les prévisions des analystes.

Il s'agit d'une situation assez rare car 97% des entreprises couvertes par SimplyWall St disposent de données financières passées.

Prévisions de croissance des bénéfices et des revenus

SEHK:876 - Estimations futures des analystes et données financières antérieures (HKD Millions )
Date	Recettes	Les revenus	Flux de trésorerie disponible	Cash from Op	Moy. Nombre d'analystes
6/30/2024	182	-57	-64	-61	N/A
3/31/2024	184	-25	-55	-48	N/A
12/31/2023	186	7	-47	-36	N/A
9/30/2023	188	11	-38	-22	N/A
6/30/2023	190	14	-29	-8	N/A
3/31/2023	191	-55	-51	-33	N/A
12/31/2022	191	-123	-73	-59	N/A
9/30/2022	196	-139	-167	-143	N/A
6/30/2022	200	-155	-262	-227	N/A
3/31/2022	205	-76	-212	-175	N/A
12/31/2021	210	2	-162	-123	N/A
9/30/2021	210	15	-65	-40	N/A
6/30/2021	211	27	32	42	N/A
3/31/2021	197	-6	-15	6	N/A
12/31/2020	184	-40	-61	-31	N/A
9/30/2020	196	-203	1	34	N/A
6/30/2020	209	-366	63	100	N/A
3/31/2020	230	-360	19	46	N/A
12/31/2019	252	-355	-24	-8	N/A
9/30/2019	243	-186	-81	-63	N/A
6/30/2019	234	-18	-139	-118	N/A
3/31/2019	238	-20	-87	-62	N/A
12/31/2018	242	-22	-34	-7	N/A
9/30/2018	247	-13	N/A	N/A	N/A
6/30/2018	252	-4	-30	-12	N/A
3/31/2018	239	1	N/A	-3	N/A
12/31/2017	227	6	N/A	6	N/A
6/30/2017	195	2	N/A	22	N/A
3/31/2017	192	0	N/A	16	N/A
12/31/2016	188	-2	N/A	11	N/A
6/30/2016	27	19	N/A	3	N/A
3/31/2016	63	5	N/A	30	N/A
12/31/2015	100	-10	N/A	57	N/A
9/30/2015	376	-77	N/A	-14	N/A
6/30/2015	356	-123	N/A	-85	N/A
3/31/2015	360	-107	N/A	-106	N/A
12/31/2014	363	-90	N/A	-127	N/A
9/30/2014	357	-56	N/A	-53	N/A
6/30/2014	351	-23	N/A	21	N/A
3/31/2014	334	-33	N/A	21	N/A
12/31/2013	316	-44	N/A	21	N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: Données insuffisantes pour déterminer si la croissance des bénéfices prévue de 876 est supérieure au taux d'épargne ( 2.3% ).

Bénéfices vs marché: Données insuffisantes pour déterminer si les bénéfices de 876 devraient croître plus rapidement que le marché Hong Kong

Croissance élevée des bénéfices: Données insuffisantes pour déterminer si les bénéfices de 876 devraient augmenter de manière significative au cours des 3 prochaines années.

Chiffre d'affaires vs marché: Données insuffisantes pour déterminer si les revenus de 876 devraient croître plus rapidement que le marché Hong Kong.

Croissance élevée des revenus: Données insuffisantes pour déterminer si les revenus de 876 devraient croître plus rapidement que 20% par an.

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

ROE futur: Données insuffisantes pour déterminer si le retour sur capitaux propres de 876 devrait être élevé dans 3 ans

Kaisa Health Group Holdings Croissance future

Future contrôle des critères 0/6

Informations clés

Mises à jour récentes de la croissance future

Kaisa Health Group Holdings Limited Provides Group Earnings Guidance for the Six Months Ended 30 June 2023

Kaisa Health Group Holdings Limited Provides Unaudited Earnings Guidance for the Six Months Ended 30 June 2022

Kaisa Health Group Holdings Limited Provides Unaudited Consolidated Earnings Guidance for the Year Ended 31 December 2021

Recent updates

Kaisa Health Group Holdings Limited Announces Appointment of Executive Directors

First half 2024 earnings released: HK$0.005 loss per share (vs HK$0.008 profit in 1H 2023)

Investors Aren't Buying Kaisa Health Group Holdings Limited's (HKG:876) Revenues

New major risk - Market cap size

Kaisa Health Group Holdings Limited to Report First Half, 2024 Results on Aug 27, 2024

Here's Why Shareholders Should Examine Kaisa Health Group Holdings Limited's (HKG:876) CEO Compensation Package More Closely

Kaisa Health Group Holdings Limited Announces Board Retirements

Kaisa Health Group Holdings Limited, Annual General Meeting, Jun 14, 2024

Full year 2023 earnings released: EPS: HK$0.002 (vs HK$0.024 loss in FY 2022)

Kaisa Health Group Holdings Limited to Report Fiscal Year 2023 Results on Mar 25, 2024

Benign Growth For Kaisa Health Group Holdings Limited (HKG:876) Underpins Stock's 30% Plummet

Kaisa Health Group Holdings Limited's (HKG:876) Prospects Need A Boost To Lift Shares

First half 2023 earnings released: EPS: HK$0.008 (vs HK$0.019 loss in 1H 2022)

Kaisa Health Group Holdings Limited Provides Group Earnings Guidance for the Six Months Ended 30 June 2023

Kaisa Health Group Holdings Limited to Report First Half, 2023 Results on Aug 28, 2023

The Market Doesn't Like What It Sees From Kaisa Health Group Holdings Limited's (HKG:876) Earnings Yet As Shares Tumble 42%

Kaisa Health Group Holdings Limited, Annual General Meeting, Jun 21, 2023

Full year 2022 earnings released: HK$0.024 loss per share (vs HK$0 in FY 2021)

We're A Little Worried About Kaisa Health Group Holdings' (HKG:876) Cash Burn Rate

Less than half of directors are independent

Here's Why Kaisa Health Group Holdings (HKG:876) Must Use Its Cash Wisely

Kaisa Health Group Holdings Limited Announces Board Changes

First half 2022 earnings released: HK$0.019 loss per share (vs HK$0.012 profit in 1H 2021)

First half 2022 earnings released: HK$0.019 loss per share (vs HK$0.012 profit in 1H 2021)

Kaisa Health Group Holdings Limited Provides Unaudited Earnings Guidance for the Six Months Ended 30 June 2022

Kaisa Health Group Holdings Limited to Report Q2, 2022 Results on Aug 29, 2022

Kaisa Health Group Holdings Limited, Annual General Meeting, Jun 15, 2022

Less than half of directors are independent

Full year 2021 earnings released: EPS: HK$0 (vs HK$0.008 loss in FY 2020)

Kaisa Health Group Holdings Limited Provides Unaudited Consolidated Earnings Guidance for the Year Ended 31 December 2021

Executive Director Ho Lai Kwok has left the company

Co-President & Executive Director Hiu Yan Kwok has left the company

Kaisa Health Group Holdings' (HKG:876) Profits Appear To Have Quality Issues

First half 2021 earnings released: EPS HK$0.012 (vs HK$0.001 loss in 1H 2020)

First half 2021 earnings released: EPS HK$0.012 (vs HK$0.001 loss in 1H 2020)

We Think Kaisa Health Group Holdings (HKG:876) Can Afford To Drive Business Growth

An unknown buyer agreed to acquire Hangzhou Jiayue Investment Partnership/ Hangzhou Jinyun Investment Management Co., Ltd for approximately RMB 280 million.

Full year 2020 earnings released: HK$0.008 loss per share (vs HK$0.07 loss in FY 2019)

Kaisa Health Group Holdings Limited to Report Fiscal Year 2020 Results on Mar 24, 2021

Independent Non-Executive Director has left the company

Kaisa Health Group Holdings Limited Announces Executive Changes

Kaisa Health Group Holdings Limited and Shanghai Xinxing Construction Investment Co., Ltd Enter into Cooperation Agreement for the Establishment of the Project Company to Engage in the Project

Would Shareholders Who Purchased Kaisa Health Group Holdings' (HKG:876) Stock Five Years Be Happy With The Share price Today?

First half earnings released

Earnings released

Kaisa Health Group Holdings Limited to Report First Half, 2020 Results on Aug 26, 2020

Prévisions de croissance des bénéfices et des revenus

Prévisions de croissance des analystes

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

Découvrir les entreprises en croissance